A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.

The team hopes to develop the biomarker into a test that could be used in GP surgeries. Early prediction of dementia could be a gamechanger for new Alzheimer's therapies.

In the quest to improve diagnostics, new technologies are key, but so is overcoming entrenched bias.

Researchers have used an artificial intelligence model to analyse the metabolites of patients with or without ovarian cancer and have reported shocking accuracy of diagnosis.

Advancements in biosensors, notably graphene-based ones, show promise in swiftly identifying elusive lung cancer biomarkers, potentially revolutionising early diagnosis.

On-Demand Webinar featuring Dr Mo Jain, Founder & CEO of Sapient & Dr Tanya Nguyen, Head of Scientific Operations of Sapient

Researchers from MIT have developed a wearable ultrasound patch that can image breast tissue, potentially facilitating the home detection of breast cancer. The patch can be attached a bra, and shows promise in detecting small cysts.

Proteins in the brain and plasma of individuals with sporadic Alzheimer’s disease are altered, supporting the hypothesis that plasma biomarkers have utility in predicting early onset in cognitively unimpaired populations.

The high sensitivity and specificity of ddPCR assays makes the approach well-suited for screening diseases and diagnosing cancer subtypes. Here, we explore some of the ways in which medical researchers are using the technology to pioneer detection of circulating biomarkers for liquid biopsies.

Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer prognosis and treatment prediction.

On-Demand Webinar featuring Marina Cretich, Senior Researcher of the National Research Council of Italy at SCITEC-CNR

EUAs exist under FDA regulation to improve the availability of medical countermeasures, such as vaccines and diagnostic tests, during public health emergencies. With future pandemics a tangible possibility, further EUAs for other PCR tests and vaccines are all but certain.

A new study has revealed that using functional magnetic resonance techniques shows the differences in the spontaneous activity of the brain in people with Down syndrome compared to the general population.

If you were at risk of developing Alzheimer’s disease, would you want to know?

The Heatrich-BS assay is a novel low-cost sequencing method for low-cost cancer testing.

Study suggests the haplotype number for hepatitis B virus could act as a predictive biomarker for functional cure during antiviral therapies.

The first ever potential biomarker for Parkinson’s disease has been discovered.

Discovery of a new sensitive urinary biomarker could pave the way for cost-effective and large-scale screening of neurodegenerative disease.

New hope raised for the early detection and treatment of the tick-borne illness.

A new study analysing the cholesterol levels of black adults challenges traditional perceptions of its role in predicting heart disease risk.

A new study by Cedars-Sinai could identify protein biomarkers for preeclampsia.

A new study from the University of Edinburgh has identified potential gene indications associated with dyslexia.

New research suggests acute exposure to thirdhand smoke elevates biomarkers associated with skin diseases.

Key opinion leaders talk understanding the scientific and regulatory considerations for the qualification of biomarkers.

Scientists at Northwestern Medicine propose a potential biomarker for identifying small-cell lung cancer.

In this Commentary article, we investigate the applications of human stem cell modelling for identifying the ways in which neurodegenerative diseases such as Alzheimer's and Parkinson's affect the brain.

Data management for diagnostic devices is fast becoming a vital concern of the biomarkers industry. With the increased prevalence of ML and AI, this article interviews key opinion leaders from Nottingham Trent University, Apis Assay Technologies, and UCB about the future perspectives of diagnostic innovation and regulation.

Breath is the ideal biomarker matrix for the future of diagnostics. Sample collection is non-invasive, painless and easy to perform, and breath is a rich source of potential biomarkers. Potential applications for breath tests include disease detection, phenotyping, progression and treatment monitoring, and complementary diagnostics. Discover the benefits and capabilities of breath testing, and start researching breath biomarkers with Breath Biopsy®.